MET and cancer: The following experimental details from each study are presented in Table 3: cancer type, chemotherapy agent tested, cell models used (divided by chemosensitive and chemoresistant cell lines), method of MET/HGF blockade employed, observed changes in MET/HGF leading to enhanced MET signalling and the MET-dependent mechanisms of chemotherapy resistance.